Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma [Phase 2]
Phase 2 clinical trial update evaluating imatinib mesylate in combination with hydroxyurea for patients with recurrent or progressive gliobl…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
This is a post-marketing surveillance protocol update for Temozolomide (Temodal) in patients with glioblastoma, glioma, and astrocytoma; the…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma [Phase 3]
A Phase 3 trial evaluated cediranib in combination with lomustine for recurrent glioblastoma; the study has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
Clinical trial update on using combined [18F]FET PET and simultaneous MRI for follow-up in patients with recurrent glioblastoma that have be…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma [Phase 2]
A randomized Phase 2 trial evaluating CpG-ODN in glioblastoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma [Phase 1]
Phase 1 trial evaluating vandetanib (Zactima) in combination with imatinib mesylate and hydroxyurea for recurrent malignant glioma (glioblas…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Nimotuzumab in Adults With Glioblastoma Multiforma [Phase 3]
A Phase 3 trial evaluating nimotuzumab in adults with glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Procarbazine and Lomustine in Recurrent Glioblastoma [Phase 2]
This entry notes a Phase 2 clinical trial evaluating the combination of procarbazine and lomustine for recurrent glioblastoma. The update do…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma [NA]
This completed clinical trial update reports on tumor DNA and MRI/CT imaging findings in patients with grade III or grade IV malignant gliom…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma [Phase 2]
A Phase II trial evaluated sunitinib (Sutent) for recurrent anaplastic astrocytoma and glioblastoma. The results were posted in October 2012…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: BIBF 1120 in Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 study of BIBF 1120 (nintedanib) for recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of irinotecan and bevacizumab for patients with naive unresectable glioblastoma has comp…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults [Phase 1]
Phase 1 dose-escalation trial evaluating dose-intense radiotherapy with SIB-IMRT for glioblastoma in adults. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma [Phase 2]
A Phase 2 clinical trial evaluating Epothilone ZK-219477 for recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
This clinical trial update describes the status of a Phase 2 study evaluating glufosfamide in patients with recurrent glioblastoma.
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas [Phase 2]
This Phase 2 trial of Avastin in combination with temozolomide for unresectable or multifocal glioblastoma and gliosarcoma has completed and…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors [Phase 2]
A Phase 2 trial evaluated tandutinib in combination with bevacizumab for recurrent brain tumors, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) [Phase 1, Phase 2]
Phase 1/2 trial of lomustine (CCNU) plus dasatinib in recurrent glioblastoma was terminated; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma [Phase 3]
Phase 3 clinical trial evaluating intracranially implanted carmustine for newly diagnosed malignant glioma, assessing safety and efficacy. T…
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection [Phase 1]
Phase 1 exploratory study evaluating two investigational PI3K/mTOR inhibitors, XL765 (SAR245409) and XL147 (SAR245408), in patients with rec…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma [NA]
A clinical trial update describes a safety and efficacy study of intracranially implanted Carmustine for recurrent malignant glioma, with th…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Bevacizumab and Irinotecan to Treat Brain Tumors [Phase 2]
A Phase 2 trial evaluating bevacizumab in combination with irinotecan for high-grade gliomas was terminated, and results were posted in July…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) [Phase 1, Phase 2]
This clinical trial update assesses 18F-FLT PET-CT for defining tumor volumes in high-grade gliomas, including astrocytoma and glioblastoma,…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma [Phase 2]
A Phase 2 clinical trial evaluating penicillamine with a low copper diet and radiation therapy for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluated suramin plus radiation therapy for newly diagnosed glioblastoma.